Donation

The following videos, presented by Medscape Oncology, are designed for healthcare practitioners to earn certified medical education (CME) credits.

To earn these CME credits,

1.  Register for free at Medscape.org.

2. Login to your Medscape account.

3. Enter this link into your browser: https://www.medscape.org/viewarticle/958634?src=acdmpart_imf_958634

4. View these virtual courses in their entirety.

5. Complete CME/ABIMMOC/CE credit activities.
 

Note: These CME credits are valid through 10/27/2022.


 

medscape presentation with Dr. Brian Durie and S. Vincent Rajkumar

Advances in Frontline Therapy
Dr. Durie is joined by Dr. Rajkumar to discuss the latest recommendations for frontline myeloma therapy.
Moderator: Brian G.M. Durie, MD; Panelist: S. Vincent Rajkumar, MD


 

 

 

 

medscape presentation with Dr. Brian Durie and Joseph Mikhael

Approaches in Early Relapse
Dr. Mikhael joins the panel to discuss current approaches to patient management in the early relapse setting.
Moderator: Brian G.M. Durie, MD; Panelist: Joseph Mikhael, MD, MED, FRCPC

 

 

 

 

medscape presentation with Drs. Brian Durie and Ajay Chari

Novel Therapies in Relapsed/Refractory Multiple Myeloma
Dr. Chari joins Dr. Durie to present novel strategies for managing patients with heavily pretreated MM.
Moderator: Brian Durie, MD; Panelist: Ajai Chari, MD

 

 

 

 

medscape presentation with Dr. Brian Durie and NP Beth Faiman

Managing Side Effects of Novel Therapies
Dr. Faiman joins the panel to discuss interprofessional  and interdisciplinary management of side effects associated with novel therapies.
Moderator: Brian Durie, MD; Panelist: Beth Faiman, PhD, MSN, APRN-BC, AOCN, FAAN


 

 

 

 

medscape presentation with Drs. Brian Durie and Noopur Raje

Emerging Therapies for Relapsed/Refractory Multiple Myeloma
Dr. Durie welcomes Dr. Raje for a look ahead at emerging treatment strategies and ongoing clinical trials.
Moderator: Brian Durie, MD; Panelist: Noopur Raje, MD

 

 

 

 

 


Supported by independent grants from 

Amgen, Bristol Myers Squibb, GlaxoSmithKline, Sanofi Genzyme

 

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.